These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31382263)

  • 1. Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects.
    Stavrinou E; Sarafidis PA; Koumaras C; Loutradis C; Giamalis P; Tziomalos K; Karagiannis A; Papagianni A
    Kidney Blood Press Res; 2019; 44(4):679-689. PubMed ID: 31382263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients.
    Wu CF; Hou JS; Wang CH; Lin YL; Lai YH; Kuo CH; Liou HH; Tsai JP; Hsu BG
    Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32075016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study.
    Yang HY; Wu DA; Chen MC; Hsu BG
    Diab Vasc Dis Res; 2019 May; 16(3):281-288. PubMed ID: 30547685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
    Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
    Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients.
    Chang YC; Hsu BG; Liou HH; Lee CJ; Wang JH
    BMC Cardiovasc Disord; 2018 Nov; 18(1):214. PubMed ID: 30482161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study.
    Hsu BG; Liou HH; Lee CJ; Chen YC; Ho GJ; Lee MC
    Medicine (Baltimore); 2016 Apr; 95(15):e3300. PubMed ID: 27082570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin pathway inhibitors, bone metabolism and vascular health in kidney transplant patients.
    Wang YP; Sidibé A; Fortier C; Desjardins MP; Ung RV; Kremer R; Agharazii M; Mac-Way F
    J Nephrol; 2023 May; 36(4):969-978. PubMed ID: 36715822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of serum sclerostin and Dickkopf-related protein-1 proteins with future cardiovascular events and mortality in haemodialysis patients: a prospective cohort study.
    Stavrinou E; Sarafidis PA; Loutradis C; Memmos E; Faitatzidou D; Giamalis P; Koumaras C; Karagiannis A; Papagianni A
    Clin Kidney J; 2021 Apr; 14(4):1165-1172. PubMed ID: 33841862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum sclerostin level might be a potential biomarker for arterial stiffness in prevalent hemodialysis patients.
    Jin S; Zhu M; Yan J; Fang Y; Lu R; Zhang W; Zhang Q; Lu J; Qi C; Shao X; Zhang H; Jiang R; Ni Z
    Biomark Med; 2016 Jul; 10(7):689-99. PubMed ID: 27347702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Levels of Dickkopf-Related Protein 1 Decrease as Measured GFR Declines and Are Associated with PTH Levels.
    Forster CM; White CA; Turner ME; Norman PA; Ward EC; Hopman WM; Adams MA; Holden RM
    Am J Nephrol; 2020; 51(11):871-880. PubMed ID: 33238271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremic toxicity and sclerostin in chronic kidney disease patients.
    Desjardins L; Liabeuf S; Oliveira RB; Louvet L; Kamel S; Lemke HD; Vanholder R; Choukroun G; Massy ZA;
    Nephrol Ther; 2014 Nov; 10(6):463-70. PubMed ID: 25070604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
    Krishnasamy R; Tan SJ; Hawley CM; Johnson DW; Stanton T; Lee K; Mudge DW; Campbell S; Elder GJ; Toussaint ND; Isbel NM
    BMC Nephrol; 2017 Sep; 18(1):281. PubMed ID: 28870151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory recording of wave reflections and arterial stiffness during intra- and interdialytic periods in patients treated with dialysis.
    Karpetas A; Sarafidis PA; Georgianos PI; Protogerou A; Vakianis P; Koutroumpas G; Raptis V; Stamatiadis DN; Syrganis C; Liakopoulos V; Efstratiadis G; Lasaridis AN
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):630-8. PubMed ID: 25635033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic pulse wave velocity, central pulse pressure, augmentation index and chronic kidney disease progression in individuals with type 2 diabetes: a 3- year prospective study.
    Liu JJ; Liu S; Lee J; Gurung RL; Yiamunaa M; Ang K; Shao YM; Choo RWM; Tavintharan S; Tang WE; Sum CF; Lim SC
    BMC Nephrol; 2020 Aug; 21(1):359. PubMed ID: 32819303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.
    Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P
    PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volume status and arterial blood pressures are associated with arterial stiffness in hemodialysis patients.
    Erdan A; Ozkok A; Alpay N; Akkaya V; Yildiz A
    Int J Artif Organs; 2018 Jul; 41(7):378-384. PubMed ID: 29806514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.
    Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G
    Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin and Dickkopf-1 in renal osteodystrophy.
    Cejka D; Herberth J; Branscum AJ; Fardo DW; Monier-Faugere MC; Diarra D; Haas M; Malluche HH
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):877-82. PubMed ID: 21164019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications.
    Yang CY; Chang ZF; Chau YP; Chen A; Yang WC; Yang AH; Lee OK
    Nephrol Dial Transplant; 2015 Aug; 30(8):1356-63. PubMed ID: 25817223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.